Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1 is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0.547. It has been cited 11 times, with 8 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.175
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
NIGMS NIH HHS
Grant: R01 GM120159
World Health Organization
Grant: 001
National Institutes of Health
Grant: 1R01GM120159-01A1
Development of Structurally Defined Synthetic Vaccine Adjuvants
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals